Drugs / adrenocorticotropic hormone
adrenocorticotropic hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01129284 | Dec 2009 → Sep 2011 | nephrotic syndrome | Columbia University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrenocorticotropic hormone | “BACKGROUND: Adrenocorticotropic hormone (ACTH) has shown promising results in glomerular diseases resistant to conventional therapies, but the reported data have solely been...” PMID 22722778 ↗ Jun 2012 |
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01129284 ↗ |
| Known as | ACTHAR gel | “ACTHAR gel is a natural, highly purified, porcine ACTH which is both available in the US and FDA approved for use in the nephrotic syndrome.” NCT01129284 ↗ |